These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5503607)

  • 1. Studies of the rat immune response to plasmacytoma 5563 in C3H mice.
    Fakhri O; Hobbs JR
    Br J Cancer; 1970 Dec; 24(4):853-60. PubMed ID: 5503607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptors for immunoglobulin on B lymphocytes and cells of a cultured plasma cell tumor.
    Cline MJ; Sprent J; Warner NL; Harris AW
    J Immunol; 1972 Apr; 108(4):1126-8. PubMed ID: 4554011
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement and immunoglobulin levels in the serum and thoracic duct lymph of the rat.
    Kaartinen M; Kosunen TU; Mäkelä O
    Eur J Immunol; 1973 Sep; 3(9):556-9. PubMed ID: 4128974
    [No Abstract]   [Full Text] [Related]  

  • 4. Surface immunoglobulins of lymphocytes in plasmacytoma. V. The effect of RNA-rich extract from mouse plasmacytoma MOPC 104E on the immune response.
    Bhoopalam N; Chen Y; Yakulis V; Heller P
    Clin Exp Immunol; 1976 May; 24(2):357-67. PubMed ID: 1277583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming some limiting factors in tumour immunotherapy.
    Fakhri O; Hobbs JR
    Br J Cancer; 1973 Jul; 28(1):1-5. PubMed ID: 4724609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of cytotoxic T and B immunoblasts in the thoracic duct of rats bearing tumour grafts.
    Denham S; Wrathmell AB; Alexander P
    Transplantation; 1975 Feb; 19(2):102-14. PubMed ID: 1091036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune suppression in BALB/c mice bearing the plasmacytoma TEPC-183: evidence for normal lymphocyte but defective macrophage function.
    Joshua DE; Brown G; MacLennan IC
    Int J Cancer; 1979 May; 23(5):663-72. PubMed ID: 378867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of tumor growth in mice by thoracic duct drainage: relationship to blocking factor in lymph.
    Noonan FP; Gardner MA; Clunie GJ; Isbister WH; Halliday WJ
    Int J Cancer; 1974 May; 13(5):640-9. PubMed ID: 4843878
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental studies on the immunity of plasmacytoma in golden hamsters].
    Althoff J; Kinzel V; Mohr U; Pielsticker K; Seidel HJ; Urbaschek B; Versteyl R; Wieser O
    Arch Geschwulstforsch; 1968; 1(3):213-34. PubMed ID: 4177065
    [No Abstract]   [Full Text] [Related]  

  • 10. Alteration of cell-surface antigenicity of the mouse plasmacytoma. II. Lack of correlation between synthesis of myeloma protein and alteration of surface antigen.
    Ohno S; Natsu-ume-Sakai S; Migita S
    J Natl Cancer Inst; 1977 Feb; 58(2):229-37. PubMed ID: 833874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression and enhancement of allografted tumour.
    Yutoku M; Seno H; Matsuoka Y; Kitagawa M
    Immunology; 1974 Mar; 26(3):623-37. PubMed ID: 4854531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mathematical model for the quantitation of tumor and antibody-forming cell populations within an animal's body.
    Hiramoto RN; Ghanta VK; McGhee JR; Hamlin NM
    J Immunol; 1973 Nov; 111(5):1546-53. PubMed ID: 4583078
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphocyte defect in plasmacytoma-bearing mice.
    Brus I; Brent J; Hollander VP
    Br J Cancer; 1978 Apr; 37(4):545-52. PubMed ID: 646925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cellular immunity in mouse plasmocytomas].
    Lespinats G; Poupon MF
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):755-65. PubMed ID: 5050876
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy.
    Adler A; Altbaum I
    J Natl Cancer Inst; 1982 Jun; 68(6):963-9. PubMed ID: 6953275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosupression of the primary and secondary immune response by an IgM plasmacytoma (TEPC-183).
    Havas HF; Schiffman GD; Fenton M; Goodis A; Braverman S
    Immunology; 1979 Feb; 36(2):191-7. PubMed ID: 35463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.
    Haubeck HD; Kölsch E
    Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration and identification of cytotoxic antibodies and antibodies blocking the cell-mediated antitumor immunity against adenovirus type 12-induced tumors.
    Ankerst J
    Cancer Res; 1971 Jul; 31(7):997-1003. PubMed ID: 4327089
    [No Abstract]   [Full Text] [Related]  

  • 19. Surface immunoglobulins on circulating lymphocytes in mouse and human plasmacytoma.
    Heller P; Yakulis V; Bhoopalam N; Costea N; Cabana V; Nathan RD
    Trans Assoc Am Physicians; 1972; 85():192-202. PubMed ID: 4633774
    [No Abstract]   [Full Text] [Related]  

  • 20. Protection against MOPC-315 plasmacytoma by immunization with C-type particle preparations.
    Kleinman R; Dray S
    Cancer Res; 1978 Jan; 38(1):223-5. PubMed ID: 201375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.